Humacyte Share Price (NASDAQ: HUMA)
$1.56
Last updated on
Check the interactive Humacyte Stock chart to analyse performance
Humacyte stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$1.51Today's High:$1.62
3.53%
Downside
Day's Volatility :6.81%
Upside
3.41%
- 52 Weeks Low:$1.1552 Weeks High:$6.77
26.28%
Downside
52 Weeks Volatility :83.01%
Upside
76.96%
Humacyte Stock Returns
Humacyte Inc Key Stats
Check Humacyte key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Humacyte Stock including INR - Dollar returns
The Humacyte stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Humacyte investment value today
Current value as on today
₹33,443
Returns
Returns from Humacyte Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Humacyte Stock
Global Institutional Holdings in Humacyte Inc
Name
Holdings %
BlackRock Inc
5.26%
Vanguard Group Inc
4.48%
State Street Corp
2.73%
Heights Capital Management Inc
2.57%
CenterBook Partners LP
2.19%
Citadel Advisors Llc
1.86%
Analyst Recommendation on Humacyte Stock
Buy
83%Buy
16%Hold
0%Sell
Based on 12 Wall street analysts offering stock ratings for Humacyte(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Humacyte Share Price Target
What analysts predicted
Upside of 440.29%
Target:
$8.43
Current:
$1.56
Humacyte share price target is $8.43, a slight Upside of 440.29% compared to current price of $1.56 as per analysts' prediction.
Humacyte Stock Insights
Price Movement
In the last 1 month, HUMA stock has moved down by -35.2%Decreasing Revenue
Revenue is down for the last 4 quarters, 10.79M → 301.0K (in $), with an average decrease of 55.9% per quarterDecreasing Net Profit
Netprofit is down for the last 2 quarters, 39.13M → -37.65M (in $), with an average decrease of 196.2% per quarterHUMA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 144.2%HUMA vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 173.4%Price to Sales
ForHUMA every $1 of sales, investors are willing to pay $259.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Humacyte Technicals Summary
Sell
Neutral
Buy
Humacyte is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Humacyte Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -31.8% | -49.1% | -71.91% | -62.8% | -56.81% |
 | 3.92% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 2.49% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -15.42% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 11.08% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 1.0 | NA | NA | -0.42 | -2.5 | -0.5 | NA | 0.03 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $250.2M | -56.81% | 1.0 | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Humacyte Inc
Key Management of Humacyte Inc
Important FAQs about investing in HUMA Stock from India :
What is Humacyte share price today?
Humacyte share price today is $1.56 as on at the close of the market. Humacyte share today touched a day high of $1.62 and a low of $1.51.
What is the 52 week high and 52 week low for Humacyte share?
Humacyte share touched a 52 week high of $6.77 and a 52 week low of $1.15. Humacyte stock price today i.e. is closed at $1.56, lower by 76.96% versus the 52 week high.
How to invest in Humacyte Stock (HUMA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Humacyte on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Humacyte Shares that will get you 0.9615 shares as per Humacyte share price of $1.56 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Humacyte Stock (HUMA) from India?
Indian investors can start investing in Humacyte (HUMA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Humacyte stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Humacyte share’s latest price of $1.56 as on August 30, 2025 at 1:29 am IST, you will get 6.4103 shares of Humacyte. Learn more about
fractional shares .
What are the returns that Humacyte has given to Indian investors in the last 5 years?
Humacyte stock has given -56.81% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Cassava Sciences Inc$2.29
-3.78%
Collegium Pharmaceutical Inc$38.81
+1.2%
Axogen, Inc.$16.12
-0.62%
Rain Oncology Inc$3.84
-0.26%
- Scilex Holding Co
$17.84
-2.14%
Airsculpt Technologies$6.46
-3.0%
Mesoblast$13.81
-13.42%
Staar Surgical Co$27.33
-0.26%
Corbus Pharmaceuticals Holdings, Inc.$9.39
-5.15%